In the last trading session, 0.16 million AEON Biopharma Inc (AMEX:AEON) shares changed hands as the company’s beta touched 0.17. With the company’s per share price at $0.58 changed hands at -$0.02 or -2.92% during last session, the market valuation stood at $23.26M. AEON’s last price was a discount, traded about -2860.34% off its 52-week high of $17.17. The share price had its 52-week low at $0.52, which suggests the last value was 10.34% up since then. When we look at AEON Biopharma Inc’s average trading volume, we note the 10-day average is 0.25 million shares, with the 3-month average coming to 200.18K.
Analysts gave the AEON Biopharma Inc (AEON) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended AEON as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. AEON Biopharma Inc’s EPS for the current quarter is expected to be -0.18.
AEON Biopharma Inc (AMEX:AEON) trade information
Instantly AEON was in red as seen at the end of in last trading. With action -10.48%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -91.92%, with the 5-day performance at -10.48% in the red. However, in the 30-day time frame, AEON Biopharma Inc (AMEX:AEON) is 9.77% up. Looking at the short shares, we see there were 0.16 million shares sold at short interest cover period of 1.6 days.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
The 2024 estimates are for AEON Biopharma Inc earnings to increase by 242.86%.
AEON Dividends
AEON Biopharma Inc is expected to release its next quarterly earnings report in January.
AEON Biopharma Inc (AMEX:AEON)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 36.23% of AEON Biopharma Inc shares while 33.14% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 51.98%.
